Insider · CIK 0001696776

EGLINTON MANNER CARRIE

Reports to the SEC for 3 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001696776

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+2,239 sh	—	—	2,239
2026-05-14	RGENREPLIGEN CORPA Award	Director	AAward	+995 sh	—	—	5,461
2026-03-20	OSURORASURE TECHNOLOGIES INCP Purchase	Director, President & CEO	PPurchase	+32.3K sh	$2.93	+$94.6K	2,190,874
2026-03-13	OSURORASURE TECHNOLOGIES INCP Purchase	Director, President & CEO	PPurchase	+22K sh	$3.00	+$66K	2,158,574
2026-03-02	OSURORASURE TECHNOLOGIES INCA Award	Director, President & CEO	AAward	+355K sh	—	—	2,136,552
2026-03-01	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director, President & CEO	FTax Payment	−56.1K sh	$3.04	−$171K	1,903,743
2026-03-01	OSURORASURE TECHNOLOGIES INCA Award	Director, President & CEO	AAward	+129K sh	—	—	1,959,859
2026-03-01	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director, President & CEO	FTax Payment	−123K sh	$3.04	−$373K	1,781,088
2025-06-04	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director, President & CEO	FTax Payment	−146K sh	$2.90	−$423K	1,878,076
2025-06-04	OSURORASURE TECHNOLOGIES INCA Award	Director, President & CEO	AAward	+336K sh	—	—	2,024,076
2025-06-04	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director, President & CEO	FTax Payment	−47.2K sh	$2.90	−$137K	1,830,827
2025-05-15	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+1,800 sh	—	—	1,800
2025-05-15	RGENREPLIGEN CORPA Award	Director	AAward	+973 sh	—	—	4,466
2025-03-01	OSURORASURE TECHNOLOGIES INCA Award	Director, President & CEO	AAward	+462K sh	—	—	1,750,748
2025-03-01	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director, President & CEO	FTax Payment	−62.4K sh	$3.63	−$226K	1,688,366
2025-02-28	OSURORASURE TECHNOLOGIES INCP Purchase	Director, President & CEO	PPurchase	+28.7K sh	$3.49	+$100K	1,288,334
2025-02-27	OSURORASURE TECHNOLOGIES INCP Purchase	Director, President & CEO	PPurchase	+78.6K sh	$3.15	+$247K	1,259,664
2024-06-04	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director, President & CEO	FTax Payment	−402K sh	$4.65	−$1.87M	1,181,039
2024-05-16	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+1,376 sh	—	—	1,376
2024-05-16	RGENREPLIGEN CORPA Award	Director	AAward	+701 sh	—	—	3,493
2024-03-01	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director, President & CEO	FTax Payment	−29.6K sh	$7.19	−$213K	1,582,657
2024-03-01	OSURORASURE TECHNOLOGIES INCA Award	Director, President & CEO	AAward	+261K sh	—	—	1,612,304
2023-06-04	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director, President & CEO	FTax Payment	−47.2K sh	$5.48	−$259K	1,351,616
2023-05-18	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+1,487 sh	—	—	1,487
2023-05-18	RGENREPLIGEN CORPA Award	Director	AAward	+686 sh	—	—	2,167
2023-03-01	OSURORASURE TECHNOLOGIES INCA Award	Director, President & CEO	AAward	+258K sh	—	—	1,398,827
2022-06-04	OSURORASURE TECHNOLOGIES INCA Award	Director, President & CEO	AAward	+815K sh	$4.91	+$4M	814,830
2022-06-04	OSURORASURE TECHNOLOGIES INCA Award	Director, President & CEO	AAward	+326K sh	$4.91	+$1.6M	1,140,762
2022-05-26	RGENREPLIGEN CORPA Award	Director	AAward	+1,024 sh	—	—	1,481
2022-05-26	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+2,488 sh	—	—	2,488
2022-03-16	RGENREPLIGEN CORPP Purchase	Director	PPurchase	+625 sh	$175.02	+$109K	2,106
2022-03-07	DGXQUEST DIAGNOSTICS INCF Tax Payment	SVP, Advanced Diagnostics	FTax Payment	−7,947 sh	$130.09	−$1.03M	48,391
2022-03-07	DGXQUEST DIAGNOSTICS INCA Award	SVP, Advanced Diagnostics	AAward	+16.2K sh	$130.09	+$2.1M	56,338
2022-02-24	DGXQUEST DIAGNOSTICS INCA Award	SVP, Advanced Diagnostics	AAward	+3,915 sh	—	—	32,346
2022-02-24	DGXQUEST DIAGNOSTICS INCA Award	SVP, Advanced Diagnostics	AAward	+7,830 sh	—	—	40,176
2022-02-24	DGXQUEST DIAGNOSTICS INC · Non-Qualifed Stock Option (right to buy)A Award	SVP, Advanced Diagnostics	AAward	+19K sh	—	—	19,009
2022-02-23	DGXQUEST DIAGNOSTICS INCF Tax Payment	SVP, Advanced Diagnostics	FTax Payment	−1,368 sh	$130.09	−$178K	28,882
2022-02-23	DGXQUEST DIAGNOSTICS INCF Tax Payment	SVP, Advanced Diagnostics	FTax Payment	−609 sh	$130.23	−$79.3K	28,431
2021-05-13	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+1,151 sh	—	—	1,151
2021-05-13	RGENREPLIGEN CORPA Award	Director	AAward	+457 sh	—	—	457
2021-03-09	DGXQUEST DIAGNOSTICS INCA Award	SVP, Advanced Diagnostics	AAward	+13.2K sh	$115.42	+$1.52M	36,394
2021-03-09	DGXQUEST DIAGNOSTICS INCF Tax Payment	SVP, Advanced Diagnostics	FTax Payment	−6,165 sh	$115.42	−$712K	30,250
2021-02-24	DGXQUEST DIAGNOSTICS INCF Tax Payment	SVP, Advanced Diagnostics	FTax Payment	−611 sh	$121.19	−$74K	23,213
2021-02-23	DGXQUEST DIAGNOSTICS INCF Tax Payment	SVP, Advanced Diagnostics	FTax Payment	−1,017 sh	$121.15	−$123K	23,824
2021-02-17	DGXQUEST DIAGNOSTICS INCA Award	SVP, Advanced Diagnostics	AAward	+4,926 sh	—	—	24,841
2021-02-17	DGXQUEST DIAGNOSTICS INC · Non-Qualifed Stock Option (right to buy)A Award	SVP, Advanced Diagnostics	AAward	+27.6K sh	—	—	27,633
2021-01-04	DGXQUEST DIAGNOSTICS INCF Tax Payment	SVP, Advanced Diagnostics	FTax Payment	−2,640 sh	$119.00	−$314K	19,896
2020-06-11	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+2,794 sh	—	—	2,794
2020-04-27	DGXQUEST DIAGNOSTICS INCS Sale	SVP, Advanced Diagnostics	SSale	−2,500 sh	$112.03	−$280K	24,890
2020-04-27	DGXQUEST DIAGNOSTICS INCS Sale	SVP, Advanced Diagnostics	SSale	−2,500 sh	$110.00	−$275K	22,390

Recent filings

Accepted (ET)
May 184
EGLINTON MANNER CARRIE0001193125-26-228893
SEC(opens sec.gov)
Mar 234
EGLINTON MANNER CARRIE0001470831-26-000310
SEC(opens sec.gov)
Mar 164
EGLINTON MANNER CARRIE0001470831-26-000281
SEC(opens sec.gov)
Mar 34
EGLINTON MANNER CARRIE0001470831-26-000241
SEC(opens sec.gov)
Jun 54
EGLINTON MANNER CARRIE0001062993-25-011071
SEC(opens sec.gov)
May 194
EGLINTON MANNER CARRIE0000950170-25-074747
SEC(opens sec.gov)
Mar 44
EGLINTON MANNER CARRIE0001062993-25-004316
SEC(opens sec.gov)
Mar 34
EGLINTON MANNER CARRIE0001062993-25-004056
SEC(opens sec.gov)
Feb 274
EGLINTON MANNER CARRIE0001062993-25-003843
SEC(opens sec.gov)
Jun 64
EGLINTON MANNER CARRIE0001062993-24-012025
SEC(opens sec.gov)
May 204
EGLINTON MANNER CARRIE0000950170-24-062601
SEC(opens sec.gov)

Companies

Address

C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100

WALTHAM, MA, 02453